Market Tracker

05/22 6:01pm ET

Alexza Pharmaceuticals Inc (NASDAQ:ALXA)

1.04
Delayed Data
As of May 22
 +0.0601 / +6.13%
Today’s Change
0.86
Today|||52-Week Range
5.27
-30.20%
Year-to-Date
No recent news for Alexza Pharmaceuticals Inc.

Today’s Trading

Previous close0.98
Today’s open0.98
Day’s range0.95 - 1.08
Volume118,295
Average volume (3 months)60,035
Market cap$19.0M
Dividend yield--
Data as of 4:00pm ET, 05/22/2015

Growth & Valuation

Earnings growth (last year)+13.03%
Earnings growth (this year)+16.91%
Earnings growth (next 5 years)--
Revenue growth (last year)-88.38%
P/E ratioNM
Price/Sales4.76
Price/Book--

Competitors

 Today’s
change
Today’s
% change
RTGNRuthigen Inc+0.02+0.50%
ECTEEcho Therapeutics In...-0.03-1.82%
KBIOKaloBios Pharmaceuti...-0.02-3.59%
CLRBCellectar Bioscience...-0.03-1.11%
Data as of 4:00pm ET, 05/22/2015

Financials

Next reporting dateAugust 6, 2015
EPS forecast (this quarter)-$0.64
Annual revenue (last year)$5.6M
Annual profit (last year)-$36.7M
Net profit margin-660.53%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Thomas Braxton King
Chief Operations Officer &
Executive VP-Operations
Robert A. Lippe
Corporate headquarters
Mountain View, California

Forecasts